Article ID Journal Published Year Pages File Type
5629721 Journal of Clinical Neuroscience 2017 5 Pages PDF
Abstract

•The first report of AIRE polymorphism in myasthenia gravis (MG).•Significantly higher frequencies of rs3761389 G allele in MG group and mild subgroup.•Rs3761389 variant is associated with the susceptibility of MG.•After adjusting for confounders, rs3761389 genotype is not associated with MG severity.

Polymorphism in autoimmune regulator (AIRE) gene is associated with various autoimmune disorders. Abnormal AIRE expression is associated with the development of myasthenia gravis (MG). We investigated the association of polymorphism in AIRE gene and the clinical features and severity of MG. The frequencies of alleles and genotypes were compared between 480 MG patients and 487 healthy controls, as well as among subgroups of MG patients. The frequencies of rs3761389 G allele in MG group (OR = 1.213, CI 95% 1.014-1.451, p = 0.035) and in mild (Oosterhuis score 0-2) subgroup (OR = 1.393, CI 95% 1.110-1.751, p = 0.004) were significantly higher than those in the control group. There were significant differences in the frequencies of rs3761389 genotypes (OR = 1.20, CI 95% 1.00-1.43, p = 0.046, log-additive model) and mild subgroup (OR = 1.32, CI 95% 1.03-1.69, p = 0.0058, log-additive model) compared with the control group. A Logistic regression analysis did not identify rs3761389 genotype as an independent risk factor to predict the severity of MG. This study provides the necessary preliminary data on the association with rs3761389 in AIRE gene with the susceptibility of MG, but not with the severity of MG.

Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , , , , , , , , ,